C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2006
11/16/2006	WO2006122319A2 Histone deacetylase inhibitors
11/16/2006	WO2006121648A2 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
11/16/2006	WO2006121095A1 Substituted acrylamide derivative and pharmaceutical composition comprising the same
11/16/2006	WO2006120573A2 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
11/16/2006	WO2006119713A2 Antineoplastic compounds and pharmaceutical compositions thereof
11/16/2006	WO2006119676A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease
11/16/2006	WO2006119675A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease
11/16/2006	WO2006119674A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease
11/16/2006	WO2006119673A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	US20060258864 Process for Preparaing 1-Methoxymethyl 5,5-Diphenylbarbituric Acid
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060258661 N-(pyridin-2-ylmethyl)-4-methyl-3-oxo-4-aza-5 alpha -androst-1-en-17 beta -acetamide; enhancement of weakened muscle tone; osteoporosis, bone disorders; ; periodontal disease, frailty, aging skin, male hypogonadism, postmenopausal symptoms, inflammatory arthritis, cachexia, Alzheimer's disease
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060257987 Ppar modulators
11/16/2006	US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/16/2006	CA2607934A1 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids
11/16/2006	CA2607298A1 Antineoplastic compounds and pharmaceutical compositions thereof
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720853A1 Novel polymorphic form of imatinib mesylate and a process for its preparation
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720845A1 Isothiourea derivatives
11/15/2006	EP1720841A2 Quinazoline derivatives and therapeutic use thereof
11/15/2006	EP1720840A2 Methods to manufacture 1,3-dioxolane nucleosides
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006	EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1863780A Protein kinase inhibitors and uses thereof
11/14/2006	US7135569 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135476 Corticotropin releasing factor antagonists; anxiolytic agents; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,8'-(7H)quinazoline]; (2,3,5',6',-Tetrahydro)-2'-methyl-4'-(N-propyl-N-cylopropylmethyl-amino) spiro[(1H)indene-1,7'-(5H)cyclopentapyrimidine]
11/14/2006	US7135475 Antidiabetic agents
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135467 HIV integrase inhibitors
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006119451A1 Pyrimidines and pyrazines useful as modulators of ion channels
11/09/2006	WO2006118749A1 Thia-tetraazaacenaphthylene kinase inhibitors
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006117743A1 Substituted aromatic compounds as antidiabetic agents
11/09/2006	WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	WO2006117358A1 New heterocyclylethylamide derivatives
11/09/2006	WO2006117356A1 New heterocyclylethylbenzamide derivatives
11/09/2006	WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	WO2006117197A1 Antitumoral tetrahydro-pyrimidines
11/09/2006	WO2006048336B1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents
11/09/2006	WO2006028963A3 Substituted heterocyclic compounds and uses thereof
11/09/2006	WO2005074603A3 Aminobenzoxazoles as therapeutic agents
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252779 (3,4-Dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amine
11/09/2006	US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006	CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006	CA2605784A1 Antitumoral tetrahydro-pyrimidines
11/08/2006	EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006	EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006	EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006	EP1718620A1 Pyrimidine derivatives as cannabinoid receptor modulators
11/08/2006	EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	CN1860121A Substituted imidazopyrimidines for the prevention and treatment of cancer
11/08/2006	CN1860106A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1860105A Process for producing 6, 7-bis (2-methoxyethoxy)-quinazolin-4-one
11/08/2006	CN1860104A 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
11/08/2006	CN1858040A 5,8-disubstituted quinazoline and its preparing method and use
11/08/2006	CN1858038A Oxo fluoroalkyl sulfamide compound and its preparing method and use
11/07/2006	US7132681 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132537 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132413 Contacting liquid contacting surface of drug delivery system with a thrombosis-preventing liquid containing taurolidine, taurultam or a mixture and an anticoagulant agent other than taurolidine and taurultam
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006	CA2252515C Pharmaceutical compositions for prevention and treatment of central nervous system disorders
11/02/2006	WO2006116764A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/02/2006	WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006	WO2006116401A1 C-5 substituted quinazolinone derivatives as selective estrogen receptor beta modulators
11/02/2006	WO2006116007A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
11/02/2006	WO2006115652A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006	WO2006115237A1 Process for producing 4-amino-2-alkylthio-5-pyrimidinecarbaldehyde
11/02/2006	WO2006114572A2 Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes
11/02/2006	WO2006114409A1 Pyrimidines reacting with o6-alkylguanine-dna alkyltransferase
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006114220A1 Herbicidally active phenylsulphonyl-urea
11/02/2006	WO2005113515A8 Pyrimidines for use as plk inhibitors

1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 427